Target Corporation
—- Market cap
- —
- Debt
- —
- Cash
- −$250.00M
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: TGT stock price vs ORCL: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at ORCL's multiple
Needs ORCL P/E.
Implied fair value · at TGT's multiple
Needs TGT P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
15 period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Target Corporation · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Oracle Corporation · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Walmart Inc.
TGT vs WMT
AMAZON COM INC
TGT vs AMZN
COSTCO WHOLESALE CORP /NEW
TGT vs COST
BEST BUY CO INC
TGT vs BBY
ROSS STORES, INC.
TGT vs ROST
NORDSTROM INC
TGT vs JWN
Microsoft Corporation
TGT vs MSFT
Alphabet Inc.
TGT vs GOOGL
International Business Machines Corporation
TGT vs IBM
Cisco Systems, Inc.
TGT vs CSCO
Salesforce, Inc.
TGT vs CRM
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe TGT can reaccelerate revenue and expand margins from current levels, then the current multiple may be attractive because TGT trades well below ORCL on P/E and P/S; otherwise, the valuation discount is justified by TGT’s weaker growth, lower margins, and lower profitability.
TGT trades at a meaningful discount to ORCL on earnings and revenue-based valuation, with a 16.0x P/E versus 24.1x and 0.6x P/S versus 6.0x. The implied price of $195.61 suggests 50.2% upside, but ORCL range and DCF range show wide dispersion, so the gap is not a clean standalone signal.
Supporting Metrics